The Nation - News from June 30, 1987
The Food and Drug Administration has approved the first U.S. human testing of a new drug that appeared to boost immune systems and lessened some symptoms in AIDS patients during overseas trials, officials confirmed. The drug, AS101, was developed at Bar-Ilan University in Ramat Gan, Israel, by scientists who were searching specifically for synthetic substances that would improve immune system function, according to the National Patent Development Corp., which is developing the drug in the United States.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
